Freya Biosciences

#Clinical trial #Freya Biosciences #Women's health

Freya Biosciences reports positive data on IVF therapeutic 

Immunology company Freya Biosciences has reported positive Phase I results for its treatment for IVF-related embryo implantation failure.  FB301, a defined multi-strain Lactobacillus consortium developed using Freya’s Dyscover platform, was safe and well tolerated in healthy female subjects, with all primary and secondary endpoints met.  The trial was a… Read More

#News

#Bill & Melinda Gates Foundation #Export and Investment Fund of Denmark (EIFO) #Financing #Freya Biosciences #Women's health

Over $10.4 million invested in women’s and infant health drug 

Women’s health biotech Freya Biosciences has received a $10.4 million strategic investment from the Bill & Melinda Gates Foundation with $1.4 million additional financing from current investor Export and Investment Fund of Denmark (EIFO).  The funds will be used to develop microbial immunotherapies for the treatment of bacterial vaginosis (BV)… Read More

#Business & Investment #News